They were also more than twice as likely to make a full recovery compared with the control group. The firm behind the treatment, known as SNG001, said the preliminary results suggested “a major breakthrough” in the pandemic. But if confirmed the treatment could revolutionize the way Covid-19 is dealt with in hospitals. Last month a Britain-based team of researchers lead by the University of Oxford announced they had successfully reduced the risk of death among seriously ill patients by administering the commonly available steroid dexamethasone. Several countries have also issued the emergency authorization for treatment with anti-viral remdesivir.

Source: Manila Times July 20, 2020 12:22 UTC